Cystatin C and galectin-3 as therapeutic targets in heart failure.

IF 2.6 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Therapeutic Advances in Cardiovascular Disease Pub Date : 2018-08-01 Epub Date: 2018-05-31 DOI:10.1177/1753944718778470

Christos Zivlas, Filippos Triposkiadis, Stelios Psarras, Gregory Giamouzis, Ioannis Skoularigis, Stavros Chryssanthopoulos, Alkistis Kapelouzou, Steve Ramcharitar, Edward Barnes, Evangelos Papasteriadis, Dennis Cokkinos

引用次数: 3

查看原文本刊更多论文

半胱抑素C和半乳糖凝集素-3作为心力衰竭的治疗靶点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutic Advances in Cardiovascular Disease CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

3.50

自引率

0.00%

发文量

审稿时长

9 weeks

期刊介绍： The journal is aimed at clinicians and researchers from the cardiovascular disease field and will be a forum for all views and reviews relating to this discipline.Topics covered will include: ·arteriosclerosis ·cardiomyopathies ·coronary artery disease ·diabetes ·heart failure ·hypertension ·metabolic syndrome ·obesity ·peripheral arterial disease ·stroke ·arrhythmias ·genetics